Columbus Circle Investors trimmed its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 17.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 178,532 shares of the medical instruments supplier’s stock after selling 38,318 shares during the quarter. Columbus Circle Investors owned about 0.36% of Merit Medical Systems worth $7,561,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in MMSI. LS Investment Advisors LLC raised its stake in Merit Medical Systems by 8.1% during the 2nd quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock worth $141,000 after buying an additional 277 shares during the period. Advisors Asset Management Inc. raised its stake in Merit Medical Systems by 28.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock worth $142,000 after buying an additional 820 shares during the period. Ameritas Investment Partners Inc. raised its stake in Merit Medical Systems by 20.9% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock worth $163,000 after buying an additional 738 shares during the period. SG Americas Securities LLC acquired a new position in Merit Medical Systems during the 3rd quarter worth approximately $189,000. Finally, Riverhead Capital Management LLC raised its stake in Merit Medical Systems by 67.7% during the 2nd quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock worth $198,000 after buying an additional 2,098 shares during the period. 89.47% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Merit Medical Systems, Inc. (MMSI) Stake Lessened by Columbus Circle Investors” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/11/21/merit-medical-systems-inc-mmsi-stake-lessened-by-columbus-circle-investors.html.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) traded up $1.30 during trading on Tuesday, hitting $41.90. The stock had a trading volume of 322,300 shares, compared to its average volume of 389,328. The stock has a market capitalization of $2,038.07, a P/E ratio of 31.97, a PEG ratio of 2.75 and a beta of 1.20. Merit Medical Systems, Inc. has a 12-month low of $23.25 and a 12-month high of $45.50. The company has a current ratio of 2.78, a quick ratio of 1.43 and a debt-to-equity ratio of 0.39.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, topping the consensus estimate of $0.30 by $0.02. The firm had revenue of $179.30 million during the quarter, compared to the consensus estimate of $181.28 million. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The company’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.26 earnings per share. equities analysts expect that Merit Medical Systems, Inc. will post 1.27 EPS for the current fiscal year.

A number of research firms recently weighed in on MMSI. SunTrust Banks, Inc. set a $47.00 price target on Merit Medical Systems and gave the stock a “buy” rating in a research note on Thursday, November 16th. Zacks Investment Research raised Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 price target on the stock in a research note on Saturday, October 28th. Canaccord Genuity upped their price target on Merit Medical Systems from $45.00 to $47.50 and gave the stock a “buy” rating in a research note on Thursday, October 26th. Raymond James Financial, Inc. reaffirmed an “outperform” rating and set a $44.00 price target on shares of Merit Medical Systems in a research note on Monday, August 28th. Finally, Citigroup Inc. downgraded Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 price target on the stock. in a research note on Monday, August 28th. They noted that the move was a valuation call. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. Merit Medical Systems has an average rating of “Buy” and a consensus target price of $42.02.

In other Merit Medical Systems news, Director Kent W. Stanger sold 670 shares of the stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $42.06, for a total transaction of $28,180.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.00% of the stock is currently owned by corporate insiders.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.